D.E. Shaw & Co
IMGN

D.E. Shaw & Co’s Immunogen Inc IMGN Stock Holding History

D.E. Shaw & Co’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,522,797
Closed -$134M – 4900
2023
Q4 		$134M Sell
4,522,797
-2,472,442
-35% -$49.2M 0.12% 200
2023
Q3 		$111M Buy
6,995,239
+714,723
+11% +$11.9M 0.12% 193
2023
Q2 		$119M Buy
+6,280,516
New +$74.2M 0.12% 188
2023
Q1 		– Sell
-485,378
Closed -$2.41M – 5024
2022
Q4 		$2.41M Sell
485,378
-193,754
-29% -$1.05M ﹤0.01% 2789
2022
Q3 		$3.25M Sell
679,132
-297,795
-30% -$1.57M ﹤0.01% 2546
2022
Q2 		$4.4M Sell
976,927
-274,750
-22% -$1.19M 0.01% 2282
2022
Q1 		$5.96M Sell
1,251,677
-606,029
-33% -$3.36M 0.01% 2119
2021
Q4 		$13.8M Sell
1,857,706
-228,529
-11% -$1.42M 0.01% 1384
2021
Q3 		$11.8M Sell
2,086,235
-87,547
-4% -$506K 0.01% 1385
2021
Q2 		$14.3M Buy
2,173,782
+342,538
+19% +$2.39M 0.01% 1213
2021
Q1 		$14.8M Buy
1,831,244
+575,562
+46% +$4.7M 0.01% 1120
2020
Q4 		$8.1M Sell
1,255,682
-385,734
-24% -$2.25M 0.01% 1508
2020
Q3 		$5.91M Sell
1,641,416
-921,240
-36% -$3.72M 0.01% 1577
2020
Q2 		$11.8M Buy
2,562,656
+220,406
+9% +$937K 0.01% 1093
2020
Q1 		$7.99M Sell
2,342,250
-211,660
-8% -$925K 0.01% 1128
2019
Q4 		$13M Buy
2,553,910
+1,263,448
+98% +$4.29M 0.01% 1047
2019
Q3 		$3.12M Buy
1,290,462
+796,101
+161% +$2.11M ﹤0.01% 2027
2019
Q2 		$1.07M Buy
494,361
+10,522
+2% +$24.9K ﹤0.01% 2636
2019
Q1 		$1.31M Buy
+483,839
New +$2.1M ﹤0.01% 2437
2018
Q3 		– Sell
-11,503
Closed -$112K – 4047
2018
Q2 		$112K Sell
11,503
-102,930
-90% -$1.09M ﹤0.01% 3609
2018
Q1 		$1.2M Buy
+114,433
New +$1.13M ﹤0.01% 2367
2017
Q4 		– Sell
-293,748
Closed -$2.25M – 3788
2017
Q3 		$2.25M Buy
+293,748
New +$1.95M ﹤0.01% 1932
2017
Q2 		– Sell
-484,908
Closed -$1.88M – 3586
2017
Q1 		$1.88M Buy
484,908
+35,652
+8% +$104K ﹤0.01% 1883
2016
Q4 		$917K Buy
449,256
+402,839
+868% +$809K ﹤0.01% 2511
2016
Q3 		$124K Buy
+46,417
New +$135K ﹤0.01% 3269
2016
Q2 		– Sell
-91,297
Closed -$778K – 3586
2016
Q1 		$778K Sell
91,297
-534,832
-85% -$4.52M ﹤0.01% 2524
2015
Q4 		$8.5M Buy
626,129
+122,724
+24% +$1.51M 0.01% 1044
2015
Q3 		$4.83M Buy
503,405
+478,399
+1,913% +$6.99M 0.01% 1418
2015
Q2 		$360K Sell
25,006
-212,169
-89% -$2.33M ﹤0.01% 3343
2015
Q1 		$2.12M Sell
237,175
-387,994
-62% -$2.81M ﹤0.01% 1963
2014
Q4 		$3.81M Buy
+625,169
New +$5.72M ﹤0.01% 1771

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

D.E. Shaw & Co's IMGN Position: Q1 2024 in Review

D.E. Shaw & Co sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 4,522,797 shares — an estimated $134M sold.

D.E. Shaw & Co first reported a position in IMGN in Q4 2014 and held it in 31 quarters. The position peaked at $134M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • D.E. Shaw & Co reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 4,522,797 Immunogen Inc shares in Q1 2024, an estimated $134M.
  • D.E. Shaw & Co first reported a position in Immunogen Inc in Q4 2014 and held it in 31 quarters.
  • D.E. Shaw & Co's Immunogen Inc position peaked at $134M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.